Vtv Therapeutics Inc. · NASDAQ:VTVT
Trails Edge Capital Partners, LP reported a 9.90% stake in Vtv Therapeutics Inc. (Schedule 13G)
Event Aug 29, 2025 · Filed Sep 8, 2025
Trails Edge Capital Partners, LP reported a 9.90% stake in Vtv Therapeutics Inc., 340,536 shares, as a passive investor on Aug 29, 2025. Filed Sep 8, 2025 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 340,536
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trails Edge Capital Partners, LP | 9.90% | 340,536 |
| Trails Edge Biotechnology Master Fund, LP | 9.90% | 340,536 |
| Ortav Yehudai | 9.90% | 340,536 |
Source
Related
- Vtv Therapeutics Inc.
- Trails Edge Capital Partners, LP
- Vtv Therapeutics Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 29, 2026
- Schedule 13G/A · Millennium Management LLC · Apr 16, 2026
- Schedule 13G · Millennium Management LLC · Mar 27, 2026
- Schedule 13D/A · Akkaraju Srinivas · Dec 9, 2025